Exactech, a renowned developer and manufacturer of innovative implants, surgical instruments, and smart technologies for joint replacement procedures, has proudly announced the successful completion of the first surgery utilizing its advanced Activit-E™ polyethylene material in conjunction with the Truliant® knee replacement system. This event is especially significant as the surgery took place at the hospital where Activit-E was originally developed by its inventor.

Activit-E™ represents a significant advancement by achieving an optimal balance between material strength and toughness through the use of chemically crosslinked polyethylene, eliminating the need for gamma irradiation technology used in previous generations. This innovation provides patients with active oxidative resistance and ensures long-term, high-performance polyethylene bearings, ultimately enhancing strength and promoting active stabilization. Dr. Muratoglu, the inventor of the initial crosslinked polyethylene and multiple generations of vitamin E antioxidant polyethylene for leading orthopedic companies, along with his dedicated team, including Ebru Oral, Ph.D., the director of biomaterials research, have introduced this groundbreaking polyethylene, marking another notable milestone in their history of innovations.

With Activit-E's recent 510(k) clearance by the Food and Drug Administration for use in Exactech knee and ankle replacements, it holds the promise of delivering improved outcomes compared to traditional highly crosslinked polyethylene options.

Source: businesswire.com